Trial Identifier: | D5985C00006 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05755932 |
Start Date: | June 2023 |
Primary Completion Date: | July 2024 |
Study Completion Date: | July 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
US, CA | San Diego, CA, US, 92103 |
US, CA | Stanford, CA, US, 94305 |
US, KS | Kansas City, KS, US, 66160 |
US, MD | Baltimore, MD, US, 21287 |
US, NC | Chapel Hill, NC, US, 27599 |
US, PA | Pittsburgh, PA, US, 15213 |